How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
about
B-type natriuretic peptide-guided treatment for heart failureCardiac biomarkers: new tools for heart failure managementB-type natriuretic peptide-guided treatment for heart failure.The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis.The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: a diagnostic accuracy systematic review.BNP and Heart Failure: Preclinical and Clinical Trial Data.Collapse query cause: the management of adult syncope in the emergency departmentRole of brain natriuretic peptide (BNP) in risk stratification of adult syncope.Diagnostic value of serum brain natriuretic peptide in syncope in children and adolescents.Utility of brain natriuretic peptide assay as a predictor of short term outcomes in patients presenting with syncope to the emergency department.Natriuretic Peptide testing in primary carePlasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection FractionN-terminal pro-brain natriuretic peptide and associated factors in the general working population: a baseline survey of the Uranosaki cohort study.Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure.N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of AtherosclerosisGuanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase CB-type natriuretic peptide-guided therapy for perioperative medicine?Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort studyAssociation of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery.Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide.Coping effectively with heart failure (COPE-HF): design and rationale of a telephone-based coping skills intervention.The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigmsNatriuretic peptides in the diagnosis and management of heart failureImproving prognosis estimation in patients with heart failure and the cardiorenal syndromeIncreased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects.Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels.NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosisUtility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?Recent advances in natriuretic peptide researchUsefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure.Comparing Sodium Intake Strategies in Heart Failure: Rationale and Design of the Prevent Adverse Outcomes in Heart Failure by Limiting Sodium (PROHIBIT) Study.Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.Serial Measurement of Amino-Terminal Pro-B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Outcome in Children With Primary Myocardial Dysfunction and Acute Decompensated Heart Failure.Mobilization of CD34+CXCR4+ stem/progenitor cells and the parameters of left ventricular function and remodeling in 1-year follow-up of patients with acute myocardial infarctionGuanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.
P2860
Q24235082-B4AB7E92-9955-4FE9-933D-B124241B9C32Q26991726-353D3816-0F89-42FF-917C-F2C20A546214Q30238936-8758F393-1D8D-42DA-B071-AF3382927674Q30436028-A2754605-F360-4E8E-A7B1-52E9B6849916Q30484159-E0215571-CF73-42DF-9AA7-32AA02E52B2AQ30909922-CB2E8C89-35FB-498B-8A7E-246B8DF62520Q33154072-6F7A5465-09CA-45A9-B37B-1419E5B04280Q33155627-1AFB60C5-DB76-47AB-A1A2-B35DFFC1842FQ33162324-B434FA1D-EA42-44D1-ADCF-8593FC3A924EQ33167274-32DAD52A-BE03-4219-A6A4-122EA0AD1085Q33572286-ACB8532C-E6F4-4464-BA20-C3EA4142517EQ33711135-9321BF51-DEEB-4E6C-B330-FD9A1320725AQ33918896-17FB527D-C6F5-49C7-B5EF-495A5295183BQ33960469-139D3C19-BC05-4E8D-B609-6C595E90E6B6Q34014190-2A0D4299-C4B9-4411-8ABC-BA9C90A1BF91Q34076973-15051926-C880-4700-BCAB-44D80917804EQ34304406-D5B5A1C8-6833-40A3-9FA1-FBA085E85A23Q34305451-AF485240-CDC0-4388-B547-B09CD7E5DF0DQ34349235-295CA888-ECC9-4288-A4DE-C7A09DF60741Q34352658-111F3BB9-41FB-477A-9635-94390BEEBC2FQ34580385-EFCC4B17-7093-4D01-B212-93D85E5C83E0Q34715439-B590DC96-2EEA-4B46-A296-E31F220A3C25Q34715709-CD0DE250-655A-4D75-8207-E78BDAA75B74Q34776882-4EA55EAF-90B6-45C2-BBB7-C47B10EBAE9DQ34990330-C33D3CBB-2685-4834-8379-35BECB5DB8ADQ35015563-B06901E8-70AA-424C-8F0B-CF76C1FEE08EQ35020305-65634682-594B-4E55-B11C-EA0E78684479Q35141782-BADF3960-1168-485E-8BD2-789503D65247Q35151512-D18AFBB3-6008-4711-B015-6228504E58B9Q35189122-BBDB32B0-9418-45FF-A609-93CA42C9FF6AQ35286926-47E41450-3EAE-42E0-B964-C903F1B5B33DQ35459776-F03EAC7B-9BF7-4377-8479-3D8067E9C413Q35554304-5126C325-5CD4-4968-A3DD-1764B53CF915Q35596099-50FA57CB-13C1-48A3-9998-2F3775976747Q35635411-03FB2D3B-24E6-4835-94C4-D3DBBABDE446Q35669321-33BB47D6-7B61-4EE6-ABFF-FD468B8EAE51Q35680958-DCFD24EF-8CAD-481F-A596-F7073B5F84F5Q35836550-C81AABC0-E482-4B5D-8559-BEAA351973FEQ35876556-FE712C11-C71F-4377-850A-08D1400D9347Q35936915-22FD2078-B8C7-4DDE-A37D-DCC885394E0D
P2860
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
How well does B-type natriuret ...... art failure: systematic review
@ast
How well does B-type natriuret ...... art failure: systematic review
@en
type
label
How well does B-type natriuret ...... art failure: systematic review
@ast
How well does B-type natriuret ...... art failure: systematic review
@en
prefLabel
How well does B-type natriuret ...... art failure: systematic review
@ast
How well does B-type natriuret ...... art failure: systematic review
@en
P2093
P2860
P356
P1433
P1476
How well does B-type natriuret ...... art failure: systematic review
@en
P2093
Annette Dobson
Eva Pietrzak
Jenny A Doust
P2860
P356
10.1136/BMJ.330.7492.625
P407
P577
2005-03-01T00:00:00Z